Skip to main content

Author: Customer Service

Linamar Completes Acquisition of Aludyne North America Assets

GUELPH, Ontario, Nov. 15, 2025 (GLOBE NEWSWIRE) — Linamar Corporation (TSX:LNR) today announced that its previously announced acquisition of select Aludyne North America assets has been completed. The deal was initially announced on October 9th for Linamar Corporation to acquire a substantial portion of Aludyne North America assets for $300 million USD. This acquisition is highly complementary to Linamar’s existing Structures and Chassis business, adding advanced capabilities in aluminum casting, precision machining, and product design. Aludyne’s portfolio includes knuckles, subframes, control arms, and axle housings, which aligns with Linamar’s strategic focus on propulsion-agnostic structural components. Upon deal completion, these Aludyne North America facilities will be integrated into the Linamar Structures Group, part of...

Continue reading

Mantiqueira USA Announces Acquisition of Hickman’s Egg Ranch, Marking U.S. Expansion

GREELEY, Colo., Nov. 14, 2025 (GLOBE NEWSWIRE) — Mantiqueira USA (MTQ USA) today announced it has entered a binding agreement to acquire Hickman’s Egg Ranch, a leading egg producer based in the Mountain and West Coast regions and ranked among the top 20 egg companies in the United States. The acquisition marks a significant milestone in MTQ USA’s launch and its long-term strategy to build a strong, scalable presence in the U.S. egg market. MTQ USA operates as a joint venture between the Pinto Family, founders of Mantiqueira, and JBS N.V. (NYSE: JBS), one of the world’s leading food companies.  “Expanding into the United States has long been a vision for our family, and taking this step through the acquisition of Hickman’s makes this moment especially meaningful,” said Leandro Pinto, Founder of Mantiqueira. “Hickman’s is a respected...

Continue reading

Algernon Closes First Tranche of its Recently Announced Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 14, 2025 (GLOBE NEWSWIRE) — Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, announces the closing of the first tranche (the “First Tranche”) of its non-brokered private placement (the “Offering”), previously announced on November 6, 2025. Gross proceeds from the First Tranche totaled CAD $177,000 from the sale of 2,528,752 units (the “Units”) at an issue price of CAD $0.07 per Unit. Certain insiders of the Company participated in the First Tranche of the Offering in the amount of CAD $37,000. The participation by insiders in the First Tranche of the Offering constitutes a “related party transaction” as defined under Multilateral...

Continue reading

Aberdeen Announces Management Addition

TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) — ABERDEEN INTERNATIONAL INC. (“Aberdeen” or the “Company”) (TSX: AAB, F:A8H, OTC:AABVF) is pleased to announce the appointment of Stephen Woodhead as the Chief Financial Officer of the Company, effective immediately. Mr. Woodhead is a graduate of the University of Cape Town and a member of the South African Institute of Chartered Accountants. Mr. Woodhead has over 30 years of experience in the resource sector, having worked for Trans Hex Group, a South African diamond producer, before relocating to Canada in 1997 as Chief Financial Officer of Trans Hex International. Mr. Woodhead is the Chief Financial Officer of Black Iron Inc. and a director of Lipari Mining. Mr. Woodhead has worked as Chief Financial Officer / VP Finance with various public companies, including Desert Sun Mining, from...

Continue reading

Genius Group files Federal Securities Class Action Lawsuit against Citadel Securities and Virtu Financial for Alleged Market Manipulation.

SINGAPORE, Nov. 14, 2025 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced it has filed a Class Action Complaint in the United States District Court for the Southern District of New York alleging that Citadel Securities LLC, and Virtu Americas LLC (the “Defendants”) engaged in a long-running market manipulation scheme that includes spoofing and naked short selling of the Company’s shares and related acts in violation of Section 10(b), Sections 9(a)(2) and 9(e) and Section 20(a) of the Securities Exchange Act of 1934. The Company believes the lawsuit sets a number of precedents with regards to the protection of shareholder interests and the Company. As such, the Company is taking action to recover damages...

Continue reading

Avicanna Reports Q3 2025

TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce and report the results of Q3 2025. Management Commentary: “Q3 reflects the continued progress of our strategy to build a diversified and sustainable biopharmaceutical business. We are pleased with the impact of our medical affairs initiatives and the strengthened engagement within the Canadian medical community, which have contributed to consecutive quarters of revenue growth in Canada. We also continued to translate our scientific leadership into tangible value through new IP and global collaborations. Despite short-term margin pressures, we remain confident...

Continue reading

Dynamix Corporation III Announces the Separate Trading of its Class A ordinary shares and Warrants Commencing November 19, 2025

Houston, TX, Nov. 14, 2025 (GLOBE NEWSWIRE) — Dynamix Corporation III (the “Company”) today announced that commencing November 19, 2025, holders of the units sold in the Company’s initial public offering may elect to separately trade the Class A ordinary shares and warrants included in the units. Class A ordinary shares and warrants that are separated will trade on the Nasdaq Stock Market LLC under the ticker symbol “DNMX” and “DNMXW,” respectively. Those units not separated will continue to trade on the Nasdaq Stock Market LLC under the symbol “DNMXU.” No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Odyssey Transfer and Trust Company, the Company’s transfer agent, in order to separate the units into Class A ordinary...

Continue reading

Dundee Corporation Extends Strong Investment Performance and Growing Royalty Revenue in Q3

TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) — “This quarter, we delivered strong net earnings that reflected the first full quarter of royalty revenue from the Borborema Gold Project and substantial investment gains across our mining portfolio.”, said Jonathan Goodman, President and Chief Executive Officer of Dundee Corporation. “With recurring cash flow now beginning to support our core cost base, we are in a stronger position to redeploy capital toward growth – reinforcing our ability to deliver sustained shareholder value.” “The announced acquisition of Maritime Resources by New Found Gold marks another pivotal validation of our long-term investment strategy.” Mr. Goodman continued. “We recognized the intrinsic value of Maritime early and supported the company through market cycles. The transaction highlights our ability to identify...

Continue reading

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results

Data from Phase 2 BESTOW trial demonstrated a favorable safety and tolerability profile, substantially reducing the metabolic, neurologic, and cardiovascular toxicities commonly associated with tacrolimus  Data supports advancement into Phase 3 development as a potential new standard for the prevention of kidney transplant rejection Strengthened balance sheet with $57.5 million financing to advance transplantation programs IRVINE, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today reported its third quarter 2025 operating and financial results and reviewed recent business highlights. “The results from our Phase 2 BESTOW trial demonstrated tegoprubart’s excellent efficacy and safety, importantly avoiding many of the long-term toxicities commonly seen with current standard-of-care...

Continue reading

OMNIQ Reports Third Quarter Financial Results

Increased Profits in the Third Quarter 2025 SALT LAKE CITY, Nov. 14, 2025 (GLOBE NEWSWIRE) — OMNIQ Corp (OTCMTS: OMQS or “omniQ” or “the Company”) today announced its financial results for the third quarter 2025. The company reported $8.8 million in revenue and $3 million gross profit. The company continues to implement its cost-reduction strategy designed to strengthen profitability and support long-term operational efficiency. Financial HighlightsRevenue: $8.8 million compared to $9.5 million year-over-year. This was attributable to the focus on more profitable revenue and the timing of some orders. Gross Profit: $3 million compared to $2 million in the three-month period for 2024. Loss from Operations: $591 thousand compared to $787 thousand year-over-year. This represents a 13.7% improvement. Continued to focus on operational...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.